CLOSE ×
Antibody research, regulatory support and production

Discover how Inotiv uses its expertise in antibody production

Approximately 7% of all pregnancies are complicated by gestational diabetes mellitus (GDM), but current methods for GDM screening and diagnosis are unreliable.

A biomedical company approached Inotiv to assist in the development of a new diagnostic test to measure plasma levels of a protein known to indicate GDM development risk.

Inotiv developed antibody assays to establish master and working banks of cell lines, before scaling up production levels and assisting with regulatory support.

Download your copy today and:

  • Gain insights on procedures for production, purification and testing as required for GMP production
  • Learn about screening for and detecting gestational diabetes mellitus (GDM) during pregnancy is a cumbersome and uncomfortable experience
  • Discover how Inotiv used its considerable experience in antibody production to perform Master Batch Records for in vitro production and purification




Download Now